Analyst Ratings for Sutro Biopharma (STRO)
STRO Rating Summary
STRO Price Target Summary
- Highest: $51.00 (Deutsche Bank)
- Lowest: $2.00 (Piper Sandler)
- Average: $17.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$17.60 (-30.4%)
* Over Last 12-Mos
Rating Score: 5.8 / 10
Percentile Rank: 62%
Avg. $ Target:
$17.60 (-30.4%)
* Over Last 12-Mos
Rating Score: 5.8 / 10
Percentile Rank: 62%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/20/2026 | Citizens | Reni Benjamin | Upgrade | Market Outperform (Market Perform) |
23.00 (N/A) |
13.07 (25.29) |
93.5% | Details |
| 6/16/2025 | Piper Sandler | Edward Tenthoff | Upgrade | Overweight (Neutral) |
2.00 (N/A) |
0.81 (25.29) |
3022.22% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
